Search results for "pluronics"
showing 3 items of 3 documents
Dispersions of nanosilica in biocompatible copolymers
2010
Dispersions of nanosilica in matrices of biocompatible copolymers were prepared by melt blending. Copolymers with variable molecular size at fixed hydrophilic/hydrophobic ratio and nanosilicas with different interfacial areas were studied. For comparison, a nanoclay was also investigated. The interfacial area played a relevant role in conferring peculiar properties on the nanohybrids. Amazingly, the macromolecule adsorbed on the nanosilica surface maintains some crystallinity which was quantitatively evaluated. In contrast, all the macromolecule anchored to the nanoclay surface is amorphous. The change of the crystalline state was reflected in the dielectric and the electrical conductivity …
Poloxamer/sodium cholate co-formulation for micellar encapsulation of Doxorubicin with high efficiency for intracellular delivery: an in-vitro bioava…
2020
Abstract Hypothesis Doxorubicin hydrochloride (DX) is widely used as a chemotherapeutic agent, though its severe side-effects limit its clinical use. A way to overcome these limitations is to increase DX latency through encapsulation in suitable carriers. However, DX has a high solubility in water, hindering encapsulation. The formulation of DX with sodium cholate (NaC) will reduce aqueous solubility through charge neutralization and hydrophobic interactions thus facilitating DX encapsulation into poloxamer (F127) micelles, increasing drug latency. Experiments DX/NaC/PEO-PPO-PEO triblock copolymer (F127) formulations with high DX content (DX-PMs) have been prepared and characterized by scat…
A fluorescence study of the loading and time stability of doxorubicin in sodium cholate/PEO-PPO-PEO triblock copolymer mixed micelles
2019
Abstract Hypothesis Doxorubicin hydrochloride (DX) is one of the most powerful anticancer agents though its clinical use is impaired by severe undesired side effects. DX encapsulation in nanocarrier systems has been introduced as a mean to reduce its toxicity. Micelles of the nonionic triblock copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) (PEO-PPO-PEO), are very promising carrier systems. The positive charge of DX confines the drug to the hydrophilic corona region of the micelles. The use of mixed micelles of PEO-PPO-PEO copolymers and a negatively charged bile salt should favour the solubilization of DX in the apolar core region of the micelles. Experiments We st…